PMC4943768_01
Fundus photograph and OCT image of a patient with nAMD in the right eye. a Fundus photograph before the first intravitreal ranibizumab injection showing normal optic disc cupping. b OCT image showing the presence of CNV and SRF.
cop-0007-0230-g01.jpg
PMC4943768_01_cop-0007-0230-g01.jpg
F1
Two years later, optical coherence tomography (OCT) detected a CNV in his right eye (fig. 1).
Fundus photograph and OCT image of the same patient with nAMD. a Fundus photograph at 4 weeks after the 25th intravitreal ranibizumab injection, and before the first intravitreal aflibercept injection showing the presence of hard exudates. b OCT image showing the residual SRF and retinal edema.
cop-0007-0230-g02.jpg
PMC4943768_01_cop-0007-0230-g02.jpg
F2
Because the size of the SRF had not decreased at 4 weeks after the 25th ranibizumab injection, ranibizumab was stopped and the patient was switched to intravitreal aflibercept injections (fig. 2).
Fundus photograph and OCT image of the same patient with nAMD. a Fundus photograph after trabeculotomy, demonstrating the absence of hard exudates. b OCT image after trabeculotomy showing that both the SRF and the retinal edema have completely disappeared.
cop-0007-0230-g03.jpg
PMC4943768_01_cop-0007-0230-g03.jpg
F3
Two weeks after surgery, the IOP had decreased to 15 mm Hg without the use of any antiglaucoma medications (fig. 3).